Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-034912
Filing Date
2022-02-11
Accepted
2022-02-10 20:44:54
Documents
1
Group Members
VERSANT AFFILIATES FUND V, L.P.VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.VERSANT VENTURE CAPITAL V (CANADA) LPVERSANT VENTURE CAPITAL V, L.P.VERSANT VENTURES V (CANADA), L.P.VERSANT VENTURES V GP-GP (CANADA), INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d258346dsc13ga.htm SC 13G/A 115803
  Complete submission text file 0001193125-22-034912.txt   117595
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2215
Versant Ventures V, LLC (Filed by) CIK: 0001619298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91159 | Film No.: 22616239
SIC: 2834 Pharmaceutical Preparations